Somatic mutational profiling and clinical impact of driver genes in Latin‐Iberian medulloblastomas: Towards precision medicine
Neuropathology · 2025
DOI: 10.1111/neup.12979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology, 2025. Verfasst von Letícia Ganem Rillo Paz Barateiro und 19 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. Hauptthemen laut MEDLINE: Medulloblastoma, Cerebellar Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Medulloblastoma (MB) is the most prevalent malignant brain tumor in children, known for its heterogeneity and treatment‐associated toxicity, and there is a critical need for new therapeutic targets. We analyzed the somatic mutation profile of 15 driver genes in 69 Latin‐Iberian molecularly characterized medulloblastomas using the Illumina TruSight Tumor 15 panel. We classified the variants based on their clinical impact and oncogenicity. Among the patients, 66.7% were MB SHH , 13.0% MB WNT , 7.3% MB Grp3 , and 13.0% MB Grp4 . Among the 63 variants found, 54% were classified as Tier I/II and 31.7% as oncogenic/likely oncogenic. We observed 33.3% of cases harboring at least one mutation. TP53 (23.2%, 16/69) was the most mutated gene, followed by PIK3CA (5.8%, 4/69), KIT (4.3%, 3/69), PDGFRA (2.9%, 2/69), EGFR (1.4%, 1/69), ERBB2 (1.4%, 1/69), and NRAS (1.4%, 1/69). Approximately 41% of MB SHH tumors exhibited mutations, TP53 (32.6%) being the most frequently mutated gene. Tier I/II and oncogenic/likely oncogenic TP53 variants were associated with relapse, progression, and lower survival rates. Potentially actionable variants in the PIK3CA and KIT genes were identified. Latin‐Iberian medulloblastomas, particularly the MB SHH , exhibit higher mutation frequencies than other populations. We corroborate the TP53 mutation status as an important prognostic factor, while PIK3CA and KIT are potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
- Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
- Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.
- Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
- Federal University of São Paulo, São Paulo, Brazil.
- Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
ORCID-Profile: Rodrigo de Oliveira Cavagna, Daniel Antunes Moreno, Rui Manuel Reis
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Hospital de Câncer de Barretos
- Public Ministry of Labor Campinas
- Brazilian Ministry of Health (MoH)
- the National Council for Scientific and Technological Development
- Brazilian National Program of Genomics and Precision Health
Zitieren
APA
Barateiro, L. G. R. P., de Oliveira Cavagna, R., Dos Reis, M. B., de Paula, F. E., Teixeira, G. R., Moreno, D. A., Bonatelli, M., Santana, I., Saggioro, F. P., Neder, L., Stavale, J. N., Malheiros, S. M. F., Garcia-Rivello, H., Christiansen, S., Nunes, S., da Costa, M. J. G., Pinheiro, J., Júnior, C. A., Mançano, B. M., & Reis, R. M. (2025). Somatic mutational profiling and clinical impact of driver genes in Latin‐Iberian medulloblastomas: Towards precision medicine. Neuropathology. https://doi.org/10.1111/neup.12979
Vancouver
Barateiro LGRP, de Oliveira Cavagna R, Dos Reis MB, de Paula FE, Teixeira GR, Moreno DA, et al. Somatic mutational profiling and clinical impact of driver genes in Latin‐Iberian medulloblastomas: Towards precision medicine. Neuropathology. 2025. doi:10.1111/neup.12979
BibTeX
@article{Barateiro2025,
author = {Barateiro, Letícia Ganem Rillo Paz and de Oliveira Cavagna, Rodrigo and Dos Reis, Mariana Bisarro and de Paula, Flávia Escremim and Teixeira, Gustavo Ramos and Moreno, Daniel Antunes and Bonatelli, Murilo and Santana, Iara and Saggioro, Fabiano Pinto and Neder, Luciano and Stavale, João Norberto and Malheiros, Suzana Maria Fleury and Garcia-Rivello, Hernan and Christiansen, Silvia and Nunes, Susana and da Costa, Maria João Gil and Pinheiro, Jorge and Júnior, Carlos Almeida and Mançano, Bruna Minniti and Reis, Rui Manuel},
title = {Somatic mutational profiling and clinical impact of driver genes in Latin‐Iberian medulloblastomas: Towards precision medicine},
journal = {Neuropathology},
year = {2025},
doi = {10.1111/neup.12979}
}
EUVIMED